Phase II Clinical and Pharmacologic Study of Radiation Therapy and Carboxyamido-triazole (CAI) in Adults with Newly Diagnosed Glioblastoma Multiforme(1)

INTRODUCTION: Carboxyamido-triazole (CAI) is a synthetic inhibitor of non-voltage-gated calcium channels that reversibly inhibits angiogenesis, tumor cell proliferation, and metastatic potential. This study examined the efficacy, safety and pharmacokinetics of oral CAI in the treatment of patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mikkelsen, Tom, Lush, Richard, Grossman, Stuart A., Carson, Kathryn A., Fisher, Joy D., Alavi, Jane B., Rosenfeld, Steve
Formato: Artigo
Idioma:Inglês
Publicado em: 2006
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3963813/
https://ncbi.nlm.nih.gov/pubmed/17080256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-006-9023-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados